We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tivozanib for Recurrent Glioblastoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01846871
First Posted: May 3, 2013
Last Update Posted: December 2, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Elizabeth R. Gerstner, MD, Massachusetts General Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: December 1, 2016